Trial Profile
A retrospective study to determine outcome predictors for uretheral injection of Botulinum toxin A to treat detrusor sphincter dyssynergia in patients with spinal cord injury
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Bladder dysfunction; Detrusor instability
- Focus Therapeutic Use
- 31 Mar 2017 New trial record